April 24th 2025, 5:00pm
By Jane Biehl Ph.D.
After a long battle with illness and seeking many specialists, I emphasize the need to self-advocate for ongoing care following my cancer diagnosis.
April 24th 2025, 3:58pm
By Alex Biese
The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma.
April 24th 2025, 3:00pm
By Ryan Scott
In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation period was successfully completed.
April 24th 2025, 1:00pm
By Spencer Feldman
In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing research to improve patient outcomes.
April 23rd 2025, 9:00pm
Optune Lua received a CE Mark for metastatic non–small cell lung cancer with immune checkpoint inhibitors or docetaxel.
April 23rd 2025, 8:00pm
By Dr. Douglas Reznick
Dr. Douglas Reznick shares advice for patients with lung or head and neck cancer who may feel overwhelmed by their diagnosis.
April 23rd 2025, 7:00pm
By Joy Anderson
A push for answers led to a rare blood disorder diagnosis after Joy’s symptoms were initially dismissed.
April 23rd 2025, 5:00pm
By Linda Cohen
As spring arrives, I embrace the season’s renewal, reflecting on my journey with cancer and the freedom I’ll feel when I stop my treatment. Life is a gift.
April 23rd 2025, 4:00pm
In patients with advanced squamous non–small cell lung cancer, ivonescimab plus chemo was associated with progression-free survival results.
April 23rd 2025, 2:59pm
The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse intrinsic pontine glioma.
April 23rd 2025, 1:00pm
April 22nd 2025, 9:00pm
By Erin Longstreth, M.S.N., RN, OCN, NEA-BC
April 22nd 2025, 8:00pm
By Dr. Matthew Matasar
April 22nd 2025, 7:00pm
By Anne M. Reb
An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer progression.
April 22nd 2025, 4:54pm
By Karen Cohn
It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.
Air Matters: Radon and the Environment
LCI Launches Screening Saves Program
Nominations Open for the End Brain Cancer Initiative’s 2025 National Patient Disease Education Initiative and HOPE Award
Bringing Together the CAR T-Cell Therapy Community